MDL 2419: In Re: New England Compounding Pharmacy, Inc., Products Liability Litigation

LEAD CASE NUMBER 1:13-md-2419

These actions share factual questions relating to injuries arising from the alleged contamination of the injectable steroid methyl-prednisolone acetate at the New England Compounding Pharmacy facility in Framingham, Massachusetts, which allegedly resulted in a multistate outbreak of hundreds of cases of fungal meningitis and other infections. These cases have been assigned to Judge F. Dennis Saylor, IV.

To view the docket entries, they can click here.

To view the Liason Counsel information, they can click here.

To view the Opinions, they can click here.